WithdrawnPhase 4

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Stopped: The study was discontinued early due to inadequate patient enrollment. No patients were enrolled.

United States0Started 2008-09

Plain-language summary

To monitor the frequency of the development of thrombocytopenia in patients with Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome receiving bivalirudin during Percutaneous Coronary Intervention

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinically Documented History of HIT/HITTS * Suspicion of HIT/HITTS Exclusion Criteria: * Bleeding Diathesis * Ischemic Stroke * Chronic Thrombocytopenia * Hematologic Malignancy * Contraindication to bivalirudin * Pregnant or nursing mothers

What they're measuring

Platelet counts

Timeframe: 6, 12, 24, 48 Hours

Trial details

NCT IDNCT00759083

SponsorThe Medicines Company

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2009-09

View on ClinicalTrials.gov More Heparin-Induced Thrombocytopenia trials